Blood filtering treatment tested for nerve disorders in egyptian patients
NCT ID NCT07197099
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how well therapeutic plasma exchange (a blood-filtering procedure) works for people with autoimmune neurological diseases. Researchers at Al-Azhar University Hospitals will follow 60 Egyptian patients to see if their symptoms and daily function improve. The goal is to gather real-world evidence on this treatment's effectiveness.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- therapeutic plasma exchange (a procedure that filters the blood to remove harmful antibodies)
- What this could lead to
- If successful, this could show that plasma exchange is a useful treatment option for certain neurological autoimmune diseases in Egyptian patients.
- What could go wrong
- This is an observational study with only 60 participants, so results may not apply to all patients. There are also risks like allergic reactions or low blood pressure during the procedure.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROLOGICAL AUTOIMMUNE DISEASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Al-Azhar University Hospitals
RECRUITINGCairo, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.